Torrent Pharmaceuticals Limited (TORNTPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.123x

Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) has a cash flow conversion efficiency ratio of 0.123x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs10.38 Billion ≈ $112.26 Million USD) by net assets (Rs84.49 Billion ≈ $913.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Torrent Pharmaceuticals Limited to measure how much of total assets are equity-financed.

Torrent Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2026)

This chart illustrates how Torrent Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Torrent Pharmaceuticals Limited (TORNTPHARM) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Torrent Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Torrent Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
China Minsheng Banking Corp Ltd
SHG:600016
0.014x
HUATEI SECS.CO GDR S/10
F:206G
N/A
Coca-Cola FEMSA S.A.B. de C.V
F:CFSL
0.074x
Joint Stock Commercial Bank for Foreign Trade of Vietnam
VN:VCB
0.151x
Nan Ya Printed Circuit Board Corp
TW:8046
0.042x
BE SEMICON.INDS NY EO091
F:BSIA
0.115x
Telia Company AB
ST:TELIA
0.136x
PERNOD RIC. SA SP.ADR 1/5
F:PER0
N/A

Annual Cash Flow Conversion Efficiency for Torrent Pharmaceuticals Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of Torrent Pharmaceuticals Limited from 2005 to 2026. For the full company profile with market capitalisation and key ratios, see Torrent Pharmaceuticals Limited stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs175.85 Billion
≈ $1.90 Billion
Rs26.32 Billion
≈ $284.64 Million
0.150x -56.05%
2025-03-31 Rs75.91 Billion
≈ $820.94 Million
Rs25.85 Billion
≈ $279.56 Million
0.341x -28.51%
2024-03-31 Rs68.56 Billion
≈ $741.47 Million
Rs32.66 Billion
≈ $353.21 Million
0.476x +24.69%
2023-03-31 Rs61.98 Billion
≈ $670.29 Million
Rs23.68 Billion
≈ $256.09 Million
0.382x +26.14%
2022-03-31 Rs59.53 Billion
≈ $643.79 Million
Rs18.03 Billion
≈ $194.99 Million
0.303x -12.07%
2021-03-31 Rs58.37 Billion
≈ $631.27 Million
Rs20.11 Billion
≈ $217.45 Million
0.344x +19.37%
2020-03-31 Rs48.23 Billion
≈ $521.61 Million
Rs13.92 Billion
≈ $150.52 Million
0.289x -24.18%
2019-03-31 Rs47.24 Billion
≈ $510.92 Million
Rs17.98 Billion
≈ $194.46 Million
0.381x +96.76%
2018-03-31 Rs46.23 Billion
≈ $499.93 Million
Rs8.94 Billion
≈ $96.70 Million
0.193x -16.90%
2017-03-31 Rs43.51 Billion
≈ $470.50 Million
Rs10.13 Billion
≈ $109.52 Million
0.233x -70.92%
2016-03-31 Rs33.89 Billion
≈ $366.56 Million
Rs27.13 Billion
≈ $293.43 Million
0.800x +146.11%
2015-03-31 Rs24.91 Billion
≈ $269.39 Million
Rs8.10 Billion
≈ $87.62 Million
0.325x +3.25%
2014-03-31 Rs19.03 Billion
≈ $205.78 Million
Rs5.99 Billion
≈ $64.82 Million
0.315x +191.92%
2013-03-31 Rs14.22 Billion
≈ $153.82 Million
Rs1.53 Billion
≈ $16.60 Million
0.108x -74.53%
2012-03-31 Rs11.97 Billion
≈ $129.49 Million
Rs5.07 Billion
≈ $54.87 Million
0.424x +9.98%
2011-03-31 Rs10.24 Billion
≈ $110.74 Million
Rs3.95 Billion
≈ $42.67 Million
0.385x +11.56%
2010-03-31 Rs8.31 Billion
≈ $89.87 Million
Rs2.87 Billion
≈ $31.04 Million
0.345x -12.83%
2009-03-31 Rs6.51 Billion
≈ $70.39 Million
Rs2.58 Billion
≈ $27.89 Million
0.396x -16.47%
2008-03-31 Rs5.10 Billion
≈ $55.11 Million
Rs2.42 Billion
≈ $26.14 Million
0.474x +164.43%
2007-03-31 Rs4.10 Billion
≈ $44.37 Million
Rs735.97 Million
≈ $7.96 Million
0.179x +81.59%
2006-03-31 Rs3.48 Billion
≈ $37.62 Million
Rs343.63 Million
≈ $3.72 Million
0.099x +23.72%
2005-03-31 Rs3.16 Billion
≈ $34.12 Million
Rs251.96 Million
≈ $2.72 Million
0.080x --

About Torrent Pharmaceuticals Limited

NSE:TORNTPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$18.75 Billion
Rs1.73 Trillion INR
Market Cap Rank
#1344 Global
#41 in India
Share Price
Rs5122.80
Change (1 day)
+4.58%
52-Week Range
Rs3514.70 - Rs5122.80
All Time High
Rs5122.80
About

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-int… Read more